Stock LIGHTLAKE THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Lightlake Therapeutics OTC Bulletin Board

Equities

US53224T1051

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Lightlake Therapeutics
2023 Indivior completes acquisition of Opiant Pharmaceuticals AN
2023 Indivior Wraps Up Deal to Buy Opiant Pharmaceuticals MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Initiates Coverage on Opiant Pharmaceuticals With Outperform Rating, $42 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPNT Stock
  4. Stock
  5. News Lightlake Therapeutics
  6. Analyst Reco.